TRIM
PFE icon

Thompson Rubinstein Investment Management’s Pfizer PFE Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.17M Buy
103,601
+211
+0.2% +$8.45K 1.34% 31
2018
Q4 		$4.28M Hold
103,390
– – 1.58% 25
2018
Q3 		$4.32M Sell
103,390
-211
-0.2% -$8.12K 1.33% 30
2018
Q2 		$3.57M Sell
103,601
-1,581
-2% -$54K 1.19% 34
2018
Q1 		$3.54M Buy
105,182
+639
+0.6% +$22K 1.21% 32
2017
Q4 		$3.59M Buy
104,543
+632
+0.6% +$21.6K 1.18% 33
2017
Q3 		$3.52M Buy
103,911
+1,371
+1% +$44.1K 1.23% 33
2017
Q2 		$3.27M Sell
102,540
-1,107
-1% -$34.9K 1.2% 34
2017
Q1 		$3.36M Sell
103,647
-2,113
-2% -$66.6K 1.22% 33
2016
Q4 		$3.26M Buy
105,760
+210
+0.2% +$6.41K 1.21% 35
2016
Q3 		$3.39M Hold
105,550
– – 1.29% 32
2016
Q2 		$3.53M Buy
105,550
+1,086
+1% +$34.7K 1.37% 30
2016
Q1 		$2.94M Buy
104,464
+40,903
+64% +$1.17M 1.2% 31
2015
Q4 		$1.95M Sell
63,561
-41,535
-40% -$1.31M 0.89% 36
2015
Q3 		$3.13M Sell
105,096
-1,202
-1% -$38.5K 1.39% 27
2015
Q2 		$3.38M Sell
106,298
-738
-0.7% -$24.1K 1.35% 29
2015
Q1 		$3.53M Sell
107,036
-3,162
-3% -$101K 1.38% 29
2014
Q4 		$3.26M Sell
110,198
-8,263
-7% -$237K 1.25% 33
2014
Q3 		$3.32M Sell
118,461
-343
-0.3% -$9.63K 1.31% 30
2014
Q2 		$3.35M Buy
118,804
+9,823
+9% +$280K 1.26% 34
2014
Q1 		$3.32M Sell
108,981
-3,827
-3% -$114K 1.33% 34
2013
Q4 		$3.28M Buy
112,808
+317
+0.3% +$9.23K 1.29% 33
2013
Q3 		$3.07M Sell
112,491
-158
-0.1% -$4.3K 1.3% 34
2013
Q2 		$2.99M Buy
+112,649
New +$3.11M 1.35% 31

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Thompson Rubinstein Investment Management's PFE Position: Q1 2019 in Review

Thompson Rubinstein Investment Management increased its Pfizer (PFE) stake by 0.2% in Q1 2019, buying an estimated $8.45K and bringing the position to 103,601 shares worth $4.17M. The position accounts for 1.34% of the portfolio, ranked #31.

Thompson Rubinstein Investment Management first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.32M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Thompson Rubinstein Investment Management held 103,601 shares of Pfizer worth $4.17M as of Q1 2019.
  • Thompson Rubinstein Investment Management bought 211 Pfizer shares in Q1 2019, an estimated $8.45K.
  • Pfizer made up 1.34% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #31 holding.
  • Thompson Rubinstein Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • Thompson Rubinstein Investment Management's Pfizer position peaked at $4.32M in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.